文献速递重症综合管理与镇静镇痛

多组学分析揭示肠道微生物群-溶血磷脂酰胆碱代谢轴驱动体外循环心脏术后炎症

A Multiomics Analysis Reveals a Gut Microbiome: LPC Metabolic Axis Driving Postoperative Inflammation in Cardiopulmonary Bypass Patients.
PubMed 文献 · Shock · 2025-09-17
一句话结论体外循环心脏术后肠道菌群与LPC代谢轴改变与术后风险相关,基于术前微生物组和代谢组构建的预测模型对ICU停留时间的平均绝对误差为1.27天、R²为0.63。

该研究纳入60例体外循环心脏手术患者,收集54份术前和33份术后样本,进行宏基因组和代谢组测序,分析肠道菌群及血清和粪便代谢物的动态变化及其与术后风险的关系。结果显示术后肠道菌群(P=0.012)、血清代谢物(P=3.50e-10)和粪便代谢物(P=0.0081)均发生显著改变,其中溶血磷脂酰胆碱(LPC)变化尤为明显,并发现微生物群对LPC代谢具有潜在调控功能,进而影响术后风险。基于术前微生物组和代谢组数据构建的术后风险预测模型对ICU停留时间的平均绝对误差为1.27天、R²为0.63。研究提供了包含超过2000个宏基因组组装基因组和300万个unigenes的资源库(catalogue GM3C)。

要点

  • 体外循环心脏术后肠道菌群(P=0.012)、血清代谢物(P=3.50e-10)和粪便代谢物(P=0.0081)均发生显著改变。
  • 溶血磷脂酰胆碱(LPC)是术后变化显著的代谢物,微生物群对LPC代谢具有潜在调控功能。
  • 基于术前微生物组和代谢组构建的预测模型对ICU停留时间的平均绝对误差为1.27天、R²为0.63。
  • 研究提供catalogue GM3C资源库,包含超过2000个宏基因组组装基因组和300万个unigenes。
  • 肠道来源信号可能参与调控非感染性炎症反应和宿主失衡,为理解体外循环术后全身并发症提供多组学框架。

适用人群与场景

  • 接受体外循环心脏手术(CSCPB)的患者,研究共纳入60例。

研究设计与关键结果

  • 研究类型为多组学队列分析,纳入60例CSCPB患者,收集54份术前样本和33份术后样本进行宏基因组和代谢组测序。
  • 术后肠道菌群显著改变(P=0.012),血清代谢物显著改变(P=3.50e-10),粪便代谢物显著改变(P=0.0081)。
  • 溶血磷脂酰胆碱(LPC)在术后变化显著,微生物群对LPC代谢具有潜在调控功能,进而影响术后风险。
  • 基于术前微生物组和代谢组数据构建的ICU停留时间预测模型平均绝对误差为1.27天,R²为0.63。
  • 研究构建了包含超过2000个宏基因组组装基因组和300万个unigenes的catalogue GM3C资源库。

证据类型、等级与局限

  • 证据类型:多组学观察性队列研究(ClinicalTrials.gov NCT04032938)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Patients undergoing cardiac surgery with cardiopulmonary bypass (CSCPB) are at substantial postoperative risk, which may be influenced by alterations in gut microbiota and metabolites. The roles of these biological changes in postoperative outcomes remain inadequately explored.

METHODS: We collected 54 preoperative samples and 33 postoperative samples from 60 CSCPB patients. Metagenomic and metabolomic sequencing were performed to identify the gut microbiota and serum and fecal metabolites. We examined the dynamic pattern of these microbiota and metabolites, as well as their associations with the postoperative risks. Additionally, we developed a predictive model for postoperative risk based on preoperative microbiome and metabolome data.

RESULTS: We revealed significant alterations of gut microbiota ( P = 0.012), serum metabolites ( P = 3.50 e-10 ), and fecal metabolites ( P = 0.0081) in patients following CSCPB, among which lysophosphatidylcholines (LPCs) exhibited notable changes. Particularly, we identified a potential regulatory function of the microbiota on LPC metabolism, which further influences the postoperative risk. The predictive model for intensive care unit stay duration achieved a mean absolute error of 1.27 days and an R² of 0.63, suggesting its utility in assessing postoperative risk. Also, our study provides a valuable resource (catalogue GM3C) for further investigation into potential medical targets in CSCPB patients, comprising more than 2,000 metagenome-assembled genomes and 3 million unigenes.

CONCLUSIONS: Our study reveals that the gut microbiome and LPC-centered metabolism form a functional network influencing postoperative risk in CSCPB patients. These findings underscore the role of gut-derived signals in modulating noninfectious inflammatory responses and host imbalance, offering a multiomics framework for decoding systemic complications beyond classical sepsis paradigms.

TRIAL REGISTRATION: ClinicalTrials.gov (NCT04032938). Registered 25 July 2019, https://clinicaltrials.gov/study/NCT04032938#study-record-dates .

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Ding W, Zhang H, Wen J, et al. A Multiomics Analysis Reveals a Gut Microbiome: LPC Metabolic Axis Driving Postoperative Inflammation in Cardiopulmonary Bypass Patients. Shock. 2025. PMID: 41166145. doi:10.1097/SHK.0000000000002722

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。